Early changes in carcinogenesis of colorectal adenomas

West Indian Medical Journal

Volumn 61, Issue 1, 2012, Pages 10-16

  Toru, S ^a   Bilezikci B ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Adenomatous polyps; Carcinogenesis; HPV

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; UVOMORULIN;

ADENOMATOUS POLYP; ADULT; ARTICLE; CARCINOGENESIS; COLON BIOPSY; COLON POLYP; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE CRYPT; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; RISK ASSESSMENT; VILLOUS ADENOMA;

ADENOMA; AGED; AGED, 80 AND OVER; CADHERINS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; COLONIC POLYPS; CYCLIN D1; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; RECTAL NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84865966111     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: 10.7727/wimj.2011.136     Document Type: Article

References (45)

1. Contu PC, Contu SS,Moreira LF. Bcl-2 Expression in rectal Cancer.Arq Gastroenterol, 2006; 43: 24-287.
2. Hamilton SR, Aaltonen LA, eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000: 103-37.
3. Koornstra JJ, de Jong S, Hollema H, de Vries EGE, Kleibeuker JH. Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature. Critical Reviews in Oncology/Haematology 2003; 45: 37-53.
4. Robbins SL, Kumar V, Abbas AK, Cotran RS, Fausto N. Robbins and Cotran pathologic basis of disease. 8th ed. Philadelphia: Saunders Elsevier; 2010: 822-5.
5. Lorenzon L, Ferri M, Emanuella Pilozzi, Torrisi MR, Ziparo V, French D. Human papillomavirus and colorectal cancer: evidences and pitfalls of published literature. Int J Colorectal Dis 2011; 26: 135-42.
6. Vogelstein B, Fearon ER, Hamilton SR, Kern ES, Preisinger AC, Leppert M et al. Genetic alterations during colorectal-tumour development. N Engl J Med 1988; 319: 525-32.
7. Kouraklis G, Theocharis S, Vamvakas P, Vagianos C, Glinavou A, Giaginis C et al. Cyclin D1 and Rb protein expression and their correlation with prognosis in patients with colon cancer. World Journal of Surgical Oncology 2006; 4: 5. Toru and Bilezikçi
8. Bukholm IK, Nesland JM. Protein Expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, Cyclin D1and pRb in human colon carcinomas. Virchow's Arch 2000; 436: 224-8.
9. Andersen SN, Rognum TO, Baka A, Clausen OPF. Ki-67:Auseful marker for the evaluation of dysplasia in ulcerative colitis. J Clin Mol Pathol 1998; 51: 327-32.
10. Tavangar SM, Shariftabrizi A, Soroush AR. Her/neu over-expression correlates with more advanced disease in Iranian colorectal cancer patients. Med Sci Monit 2005; 11: CR123-6.
11. Lai M, Luo M, Yao J, Chen P. Anal cancer in Chinese: human papillomavirus infection and altered expression of p53. World J Gastroenterol 1998; 4: 298-302.
12. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. New Engl J Med 2000; 342: 792-800.
13. Zhang J, Ding Y, Zhou Z, Li H, Zhou. Expression of human papillomavirus 16 E7 DNA in patients with colorectal adenocarcinoma. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2005; 22: 1024-6, 1044.
14. Perez LO, Abba MC, Laguens RM, Golijow CD. Analysis of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction. Colorectal Dis 2005; 7: 492-5.
15. Buyru N, Tezol A, Dalay N. P53 intronic G13964C variant in colon cancer and its association with HPV. Anticancer Res 2005; 25: 2767-9.
16. Buyru N, Budak M, Yazici H, Dalay N. P53 gene mutations are rare in human papillomavirus-associated colon cancer. Oncol Rep 2003; 10: 2089-92.
17. Zhu Q, Cao J, Li S. Detection of human papillomavirus gene in biopsies from colon carcinoma by PCR. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 1999; 13: 352-4.
18. Bodaghi S,Yamanegi K, Xiao SY, Da Costa M, Palefsky JM, Zheng ZM. Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 2005; 11: 2862-7.
19. Liang JJ, Alrawi S, Tan D. Nomenclature, molecular genetics and clinical significance of the precursor lesions in the serrated polyp pathway of colorectal carcinoma. Int J Clin Exp Pathol 2008; 1: 317-24.
20. Unal H, Selcuk H, Gokcan H, Tore E, Sar A, Korkmaz M et al. Malignancy risk of small polyps and related factors. Dig Dis Sci 2007: DOI 10.1007/s10620-007-9782-8.
21. Suzuki Y, Honma T, Hayashi S, Ajioka Y, Asakura H. Bcl-2 expression and frequency of apoptosis correlate with morphogenesis of colorectal neoplasia. J Clin Pathol 2002; 55: 212-16.
22. Zavrides HN, Zizi-Sermpetzogluo A, Panousopoulos D,Athanasas G, Elemenoglou I, Peros G. Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer. Folia Histochemica et cytobiologica 2005; 43: 31-6.
23. Saleh HA, Jackson H, Khatib G, Banerjee M. Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia. Pathology Oncology Research 1999; 5: 273-9.
24. Sun X, Gong Y, Talamonti MS, Rao S. Expression of cell adhesion molecules, cd44s and e-cadherin, and microvessel density in carcinoid tumours. Mod Pathol 2002; 15: 1333-8.
25. Hori H, Fujimori T, Fujii S, Ichikawa K, Ohkura Y, Tomita S et al. Evaluation of tumour cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma. Dis Colon Rectum 2005; 48: 938-45.
26. Houston M. Chapter 20. Breast. In: Rosai J, ed. Rosai and Ackerman's Surgical Pathology. 9th edition, volume 2. St Louis: Mosby; 2004: 1819.
27. Alao JP. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Molecular Cancer 2007; 6: 24.
28. Leedham SJ, Schier S, Thliveris AT, Halberg RB, Newton MA, Wright NA. From gene mutation to tumours-stem cells in gastrointestinal carcinogenesis. Cell Prolif 2005; 38: 387-405.
29. Demirbaş S, Sücüllü İ,Yi{dotless}ldi{dotless}ri{dotless}m Ş, Çelenk T. Influence of c-er B-2, nm23, bcl-2 and p53 protein markers on colorectal cancer. Turk J Gastroenterol 2006; 17: 13-19.
30. Bousserouel S, Lamy V, Gosse F, Lobstein A,Marescaux J, Raul F. Early modulation of gene expression used as a biomarker for chemoprevention in a preclinical model of colon carcinogenesis. Pathology International 2011; 61: 80-7.
31. Wong NACS, Morris RG, McCondochie A, Bader S, Jodrell DI, Harrison DJ. Cyclin d1 over-expression in colorectal carcinoma in vivo is dependent on ß-catenin protein dysregulation, but not k-ras mutation. J Pathol 2002; 197: 128-35.
32. Wang L, Cao X, Chen Q, Zhu T, Zhu H, Zheng L. DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation. Cancer Sci 2009; 100: 1801-8.
33. Liang J, Pan Y, Zhang D. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. Faseb J 2007; 21: 2247-56.
34. Sun N, Meng Q, Tian A. Expression of the anti-apoptotic genes Bag-1 and Bcl-2 in colon cancer and their relationship. Am J Surg 2010; 200: 341-5.
35. Kruszewski W, Kowara R, Rzepko R,Warezak C, Zielinski J, Gryglewski G et al. K-RAS point mutation, and amplification of c-myc and c-erb b2 in colon adenocarcinoma. Folia Histochemica et Cytobiologica 2004; 42: 173-9.
36. Furuta K, Yoshioka S, Okabe S, Ikeda M, Oginosawa M, Ikeda S et al. Expressions of two adenomatous poliposis coli and e-cadherin proteins on human colorectal cancers. Virchow's Arch 2003; 442: 266-70.
37. Hori H, Fujimori T, Fujii S, Ichikawa, Ohkura Y, Tomita S et al. Evaluation of tumour cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma. Dis Colon Rectum 2005; 48: 938-45.
38. Greco C, Bralet MP, Ailane N, Dubart-Kupperschmitt A, Rubinstein E, Le Naour F et al. E-cadherin/p120-catenin and tetraspanin Co-029 cooperate for cell motility control in human colon carcinoma. Cancer Res 2010; 70: 7674-83.
39. Cheng JY, Sheu LF, Lin JC, Meng CL. Detection of human papillomavirus DNA in colorectal adenomas. Arch Surg 1995; 130: 73-6.
40. Breitburd F, Coursaget P. Human papillomavirus vaccines. Cancer Biology 1999; 9: 431-5.
41. Eiben GL, Da Silva DM, Fausch SC, Le Poole IC, Nishimura MI, Kast WM. Cervical cancer vaccines: Recent advances in HPV research. Viral Immunology 2003; 16: 111-21.
42. Mammas IN, Sourvinos G, Zaravinos A, Spandiodos DA. Vaccination against human papilloma virus (HPV): Epidemiological evidence of HPV in non-genital cancers. Pathol. Oncol Res, 2010; 17: 103-19.
43. Damin DC, Caetano MB, Rosito MA. Evidence for an association of human papilloma virus infection and colorectal cancer. Eur J Surg Oncol 2007; 33: 569-74.
44. Lu DW, El-Mofty SK, Wang HL. Expression of p16, Rb, and P53 proteins in squamous cell carcinomas of the anorectal cancer. Clin Cancer Res 2003; 11: 2862-7.
45. Lee YM, Leu SY, Chiang H. Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect 2001; 34: 87-91.